She started GLP-1 RA treatment with semaglutide, and after two months growth hormone replacement with somatropin (0.2 - 0.4 mg daily) was also initiated
During the study, 10 patients were lost to follow-up and incomplete data, leaving 110 participants for the final analysis
Small vials suit a 0.25 to 0.5 mg start or a taper
[17] [24] It occurs when tissue similar to the endometrium (the lining of the womb) grows outside the uterus, commonly on the ovaries, fallopian tubes, pelvic peritoneum, and occasionally on more distant organs
The broader risk is not Brello specifically but the compounded-GLP-1 category, which the FDA has scrutinized heavily
The improved pharmacokinetic profile supports controlled experimental protocols